JPS63112998A - Production of optically active ester - Google Patents
Production of optically active esterInfo
- Publication number
- JPS63112998A JPS63112998A JP25695286A JP25695286A JPS63112998A JP S63112998 A JPS63112998 A JP S63112998A JP 25695286 A JP25695286 A JP 25695286A JP 25695286 A JP25695286 A JP 25695286A JP S63112998 A JPS63112998 A JP S63112998A
- Authority
- JP
- Japan
- Prior art keywords
- ester
- optically active
- beta
- hydroxy acid
- hydroxyacid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000002148 esters Chemical class 0.000 title claims abstract description 25
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- -1 beta- hydroxyacid ester Chemical class 0.000 claims abstract description 17
- 102000004190 Enzymes Human genes 0.000 claims abstract description 11
- 108090000790 Enzymes Proteins 0.000 claims abstract description 11
- 125000005457 triglyceride group Chemical group 0.000 claims abstract 2
- 238000005809 transesterification reaction Methods 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- SYTBZMRGLBWNTM-SNVBAGLBSA-N (R)-flurbiprofen Chemical compound FC1=CC([C@H](C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-SNVBAGLBSA-N 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 12
- 108090001060 Lipase Proteins 0.000 abstract description 4
- 102000004882 Lipase Human genes 0.000 abstract description 4
- 239000004367 Lipase Substances 0.000 abstract description 4
- 235000019421 lipase Nutrition 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 3
- 108090000371 Esterases Proteins 0.000 abstract description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 2
- 230000004048 modification Effects 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- UYXTWWCETRIEDR-UHFFFAOYSA-N Tributyrin Chemical compound CCCC(=O)OCC(OC(=O)CCC)COC(=O)CCC UYXTWWCETRIEDR-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 3
- 239000013543 active substance Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- OMSUIQOIVADKIM-UHFFFAOYSA-N ethyl 3-hydroxybutyrate Chemical compound CCOC(=O)CC(C)O OMSUIQOIVADKIM-UHFFFAOYSA-N 0.000 description 2
- MMKRHZKQPFCLLS-UHFFFAOYSA-N ethyl myristate Chemical compound CCCCCCCCCCCCCC(=O)OCC MMKRHZKQPFCLLS-UHFFFAOYSA-N 0.000 description 2
- MVLVMROFTAUDAG-UHFFFAOYSA-N ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC MVLVMROFTAUDAG-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N trilaurin Chemical compound CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- HNAGHMKIPMKKBB-UHFFFAOYSA-N 1-benzylpyrrolidine-3-carboxamide Chemical compound C1C(C(=O)N)CCN1CC1=CC=CC=C1 HNAGHMKIPMKKBB-UHFFFAOYSA-N 0.000 description 1
- XHAXVDWUMCHTCY-UHFFFAOYSA-N 2,2,2-trichloroethyl acetate Chemical compound CC(=O)OCC(Cl)(Cl)Cl XHAXVDWUMCHTCY-UHFFFAOYSA-N 0.000 description 1
- DZEDAIOKGLWUJP-UHFFFAOYSA-N 2,2,2-trichloroethyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(Cl)(Cl)Cl DZEDAIOKGLWUJP-UHFFFAOYSA-N 0.000 description 1
- ZYXNLVMBIHVDRH-UHFFFAOYSA-N 2-Methylpropyl 3-oxobutanoate Chemical compound CC(C)COC(=O)CC(C)=O ZYXNLVMBIHVDRH-UHFFFAOYSA-N 0.000 description 1
- JTXMVXSTHSMVQF-UHFFFAOYSA-N 2-acetyloxyethyl acetate Chemical compound CC(=O)OCCOC(C)=O JTXMVXSTHSMVQF-UHFFFAOYSA-N 0.000 description 1
- XHRGPLDMNNGHCX-UHFFFAOYSA-N 3-Methylbutyl 3-oxobutanoate Chemical compound CC(C)CCOC(=O)CC(C)=O XHRGPLDMNNGHCX-UHFFFAOYSA-N 0.000 description 1
- 241000590020 Achromobacter Species 0.000 description 1
- 241000588986 Alcaligenes Species 0.000 description 1
- 241000186063 Arthrobacter Species 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- REIYHFWZISXFKU-UHFFFAOYSA-N Butyl acetoacetate Chemical compound CCCCOC(=O)CC(C)=O REIYHFWZISXFKU-UHFFFAOYSA-N 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000588881 Chromobacterium Species 0.000 description 1
- 101150065749 Churc1 gene Proteins 0.000 description 1
- 102000017055 Lipoprotein Lipase Human genes 0.000 description 1
- 108010013563 Lipoprotein Lipase Proteins 0.000 description 1
- LDLDJEAVRNAEBW-UHFFFAOYSA-N Methyl 3-hydroxybutyrate Chemical compound COC(=O)CC(C)O LDLDJEAVRNAEBW-UHFFFAOYSA-N 0.000 description 1
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 1
- 241000235395 Mucor Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- QJHDFBAAFGELLO-SSDOTTSWSA-N [(2r)-butan-2-yl] butanoate Chemical compound CCCC(=O)O[C@H](C)CC QJHDFBAAFGELLO-SSDOTTSWSA-N 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- OBNCKNCVKJNDBV-UHFFFAOYSA-N butanoic acid ethyl ester Natural products CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000001087 glyceryl triacetate Substances 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- YAVJSVDUZGIQPQ-UHFFFAOYSA-N heptyl 3-oxobutanoate Chemical compound CCCCCCCOC(=O)CC(C)=O YAVJSVDUZGIQPQ-UHFFFAOYSA-N 0.000 description 1
- QNZLAXONNWOLJY-UHFFFAOYSA-N hexyl 3-oxobutanoate Chemical compound CCCCCCOC(=O)CC(C)=O QNZLAXONNWOLJY-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940017219 methyl propionate Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- IKYDDBGYKFPTGF-UHFFFAOYSA-N octyl 3-oxobutanoate Chemical compound CCCCCCCCOC(=O)CC(C)=O IKYDDBGYKFPTGF-UHFFFAOYSA-N 0.000 description 1
- IDZAUPYMMSSVHP-UHFFFAOYSA-N pentyl 3-oxobutanoate Chemical compound CCCCCOC(=O)CC(C)=O IDZAUPYMMSSVHP-UHFFFAOYSA-N 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- GVIIRWAJDFKJMJ-UHFFFAOYSA-N propan-2-yl 3-oxobutanoate Chemical compound CC(C)OC(=O)CC(C)=O GVIIRWAJDFKJMJ-UHFFFAOYSA-N 0.000 description 1
- DHGFMVMDBNLMKT-UHFFFAOYSA-N propyl 3-oxobutanoate Chemical compound CCCOC(=O)CC(C)=O DHGFMVMDBNLMKT-UHFFFAOYSA-N 0.000 description 1
- FTBUKOLPOATXGV-UHFFFAOYSA-N propyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCC FTBUKOLPOATXGV-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- JKUYRAMKJLMYLO-UHFFFAOYSA-N tert-butyl 3-oxobutanoate Chemical compound CC(=O)CC(=O)OC(C)(C)C JKUYRAMKJLMYLO-UHFFFAOYSA-N 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 229940117972 triolein Drugs 0.000 description 1
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は光学活性なエステルを酵素を用いて製造する方
法に関するものである。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a method for producing optically active esters using enzymes.
〔従来の技術と発明が解決しようとする問題点〕光学活
性なβ−ヒドロキシ酸エステルは、医薬、農薬などの生
理活性物質の光学活性出発物質として非常に有用な物質
である。現在よく知られている製造方法はパン酵母を用
いて(R,S)−β−ケト酸エステルを立体選択的に還
元する方法(B、S。[Prior art and problems to be solved by the invention] Optically active β-hydroxy acid esters are very useful substances as optically active starting materials for physiologically active substances such as medicines and agricultural chemicals. A currently well-known production method involves stereoselectively reducing (R,S)-β-keto acid ester using baker's yeast (B,S).
Deol、 D、D、R’1dley、 G、Simp
son、 Au5t、J、Chem。Deol, D, D, R'1dley, G, Simp
son, Au5t, J, Chem.
29、2459 (1976))である。この方法は簡
便であるため、実験室レベルでは大変有用であるが、数
十グラムのβ−ヒドロキシ酸エステルを得るのに数十リ
ットルの溶媒が必要であり、工業化、人里生産には不適
当であった。29, 2459 (1976)). This method is simple and very useful at the laboratory level, but it requires several tens of liters of solvent to obtain several tens of grams of β-hydroxy acid ester, making it unsuitable for industrial or human production. Met.
本発明者らは、上記問題点を解決し、工業的に有利な方
法で光学活性なβ−ヒドロキシ酸エステルを得るための
研究を行った結果、β−ケト酸エステルを還元するので
はなく、ラセミ体の(R,S)−β−ヒドロキシ酸エス
テルを原料とし、生化学的に不斉エステル交換反応を行
うことにより、効率良く光学活性なβ−アシルオキシ酸
エステルとβ−ヒドロキシ酸エステルとを得ることがで
きることを見出した。The present inventors have conducted research to solve the above problems and obtain optically active β-hydroxy acid esters using an industrially advantageous method. As a result, instead of reducing β-keto acid esters, By using racemic (R,S)-β-hydroxy acid ester as a raw material and performing a biochemical asymmetric transesterification reaction, optically active β-acyloxy acid ester and β-hydroxy acid ester can be efficiently produced. I found out what I can get.
即ら本発明は、一般式:
(Xは炭素数1から10のアルキル基を示す)で表すレ
る(R,S)−β−ヒドロキシ酸エステルを実質的に水
分の存在しない条件下で適当なエステルとエステル交換
反応を行い、R一体、S−体のどちらか一方に富む光学
活性なβ−ヒドロキシ酸エステルとβ−アシルオキシ酸
エステルに分割し、光学活性なエステルを製造するもの
である。That is, the present invention provides a method for preparing a (R,S)-β-hydroxy acid ester represented by the general formula: (X represents an alkyl group having 1 to 10 carbon atoms) under conditions substantially free of water. An optically active ester is produced by carrying out a transesterification reaction with an ester and dividing it into an optically active β-hydroxy acid ester and a β-acyloxy acid ester that are rich in either the R-isomer or the S-isomer.
次に本発明について詳細に述べる。Next, the present invention will be described in detail.
本発明において原料となるラセミ体の(R,S)−β−
ヒドロキシ酸エステルは、容易に入手でき、また容易に
合成することが可能である。例えば、3−ヒドロキシ酪
酸メチル、3−ヒドロキシ酪酸エチル等は市販されてい
る。また市販されているアセト酢酸プロピル、アセト酢
酸ブチル、アセト酢酸ペンチル、アセト酢酸ヘキシル、
アセト酢酸ヘプチル、アセト酢酸オクチル、アセト酢酸
イソプロピル、アセト酢酸イソブチル、アセト酢酸イソ
アミル、アセト酢酸tert−ブチル等を、NaBII
4等で還元することによりそれぞれ対応する (R,S
)−β−ヒドロキシ酸エステルに導くことができる。Racemic (R,S)-β- which is a raw material in the present invention
Hydroxy acid esters are readily available and can be easily synthesized. For example, methyl 3-hydroxybutyrate, ethyl 3-hydroxybutyrate, etc. are commercially available. Also commercially available propyl acetoacetate, butyl acetoacetate, pentyl acetoacetate, hexyl acetoacetate,
Heptyl acetoacetate, octyl acetoacetate, isopropyl acetoacetate, isobutyl acetoacetate, isoamyl acetoacetate, tert-butyl acetoacetate, etc., with NaBII
They correspond to each other by reducing with 4 etc. (R, S
)-β-hydroxy acid ester.
また、適当なエステルとして好ましいものはトリグリセ
リドであり、それらは容易に入手でき、例えば、トリア
セチン、トリプロビオニン、トリブチリン、トリステア
リン、トリラウリン、トリミスチン、トリオレイン等が
市販されている。その他に例えば、プロピオン酸メチル
、酪酸エチル、ラウリン酸プロピル、ミリスチン酸エチ
ル、ステアリン酸エチル、醋酸トリクロロエチル、ラウ
リン酸トリクロロエチル、エチレングリコールジアセテ
ートなどが挙げられる。Preferred suitable esters are triglycerides, which are easily available, such as triacetin, triplobionin, tributyrin, tristearin, trilaurin, trimistin, triolein, and the like. Other examples include methyl propionate, ethyl butyrate, propyl laurate, ethyl myristate, ethyl stearate, trichloroethyl acetate, trichloroethyl laurate, and ethylene glycol diacetate.
本発明において用いられる酵素は、リパーゼ、リポプロ
ティンリパーゼ、あるいはエステラーゼ等が好ましいが
、ラセミ体の(R,S)−β−ヒドロキシ酸エステルに
作用してR一体、S−体のどちらか一方と優先的に適当
なエステルとエステル交換反応する能力を有するもので
あれば種類を問わない。市販されている酵素としては、
次表に示したものが挙げられる。The enzyme used in the present invention is preferably lipase, lipoprotein lipase, or esterase, but it acts on racemic (R,S)-β-hydroxy acid ester and converts it into either R-body or S-body. Any type can be used as long as it has the ability to preferentially undergo a transesterification reaction with a suitable ester. Commercially available enzymes include
These include those shown in the table below.
また、これら酵素の他に、上記の反応を行う能力を有す
る酵素を産生ずる微生物であれば、その抽圧を問わずに
その酵素は使用できる。かかる微生物の例としては、ア
ルスロバクタ−(Arthrobacter)属、アク
ロモバクタ−(^cromobac ter)属、アル
カリゲネス(A Ica 1 igenes)属、アス
ペルギルス(Asperigillus)属、クロモバ
クテリウム(Chromobacterium) E、
カンジダ(Candida)属、ムコール(Mucor
)属、シュウトモナス(Pseudomonas)属、
リヅプス(Rhizopus)属等に属するものが挙げ
られる。In addition to these enzymes, any microorganism that produces an enzyme capable of carrying out the above reaction can be used regardless of its extraction pressure. Examples of such microorganisms include Arthrobacter genus, Achromobacter genus, Alcaligenes genus, Aspergillus genus, Chromobacterium E,
Candida spp., Mucor
) genus, Pseudomonas genus,
Examples include those belonging to the Rhizopus genus.
本発明を実施するに際し、ラセミ体−β−ヒドロキシ酸
エステル、およびトリグリセリドなどの適当なエステル
は、何れも特別の処理をせずに使用することができる。In practicing the present invention, racemic β-hydroxy acid esters and suitable esters such as triglycerides can all be used without special treatment.
ラセミ体−β−ヒドロキシ酸エステルの不斉エステル交
換反応は、(R,S)−β−ヒドロキシ酸エステルと適
当なエステル、好ましくはトリグリセリド、とを混合し
、酵素と効率良く接触させることにより行われる。The asymmetric transesterification reaction of racemic β-hydroxy acid ester is carried out by mixing (R,S)-β-hydroxy acid ester and an appropriate ester, preferably triglyceride, and bringing the mixture into efficient contact with an enzyme. be exposed.
この時の反応温度は20℃〜70℃が適当であり、特に
好ましくは25℃〜45℃である。反応時間は幅広く、
5時間から2000時間であり、反応温度を高めたり、
活性の高い酵素を用いたり、基質濃度を上下することに
より反応時間を短縮することも可能である。The reaction temperature at this time is suitably 20°C to 70°C, particularly preferably 25°C to 45°C. Reaction times vary widely;
The time is from 5 hours to 2000 hours, and the reaction temperature is increased,
It is also possible to shorten the reaction time by using a highly active enzyme or by increasing or decreasing the substrate concentration.
基質である(R,S)−β−ヒドロキシ酸エステルと適
当なエステルの割合は、l:0.5〜1:5(モル比)
であり、好ましくは1:1−1:2である。The ratio of the substrate (R,S)-β-hydroxy acid ester and the appropriate ester is 1:0.5 to 1:5 (molar ratio).
and preferably 1:1-1:2.
このようにして不斉エステル交換反応を行った後、酵素
は通常の濾過操作によって除去することが出来、そのま
ま再使用することができる。濾液である反応液を減圧蒸
留することにより、光学活性なβ−ヒドロキシ酸エステ
ルとβ−アシルオキシ酸エステルを分離取得することが
できる。After performing the asymmetric transesterification reaction in this manner, the enzyme can be removed by a normal filtration operation and can be reused as is. By distilling the reaction solution, which is a filtrate, under reduced pressure, optically active β-hydroxy acid ester and β-acyloxy acid ester can be separated and obtained.
本発明の効果を列挙すれば、以下のとおりである。 The effects of the present invention are listed below.
■ −段階の反応で高純度の光学活性体を得ることがで
きる。(2) A highly pure optically active substance can be obtained through a −-step reaction.
■ 培養液、緩衝液を必要としないため目的物を大量に
合成する際、特に大容量の反応容器を必要とはしない。■ Since no culture solution or buffer is required, there is no need for particularly large-capacity reaction vessels when synthesizing a target product in large quantities.
また、特別の装置、材料を必要としない。Moreover, no special equipment or materials are required.
■ 反応後の酵素の容易な分離、再使用が可能である。■ Enzyme can be easily separated and reused after reaction.
次に本発明を実施例によって更に詳しく説明するが、本
発明はこれらの実施例によって制限されるものではない
。EXAMPLES Next, the present invention will be explained in more detail with reference to Examples, but the present invention is not limited to these Examples.
実施例1
ラセミ体のβ−ヒドロキシブタン酸エチル66g(0,
5mol)、トリブチリン166.3 g (0,6m
ol)、およびリパーゼ「アマノPJ80gを混合し、
35℃で1゜日間攪拌後、リパーゼを濾別して反応を停
止した。Example 1 66 g of racemic ethyl β-hydroxybutanoate (0,
5 mol), tributyrin 166.3 g (0.6 m
ol), and lipase "Amano PJ 80g,
After stirring at 35°C for 1°, the reaction was stopped by filtering off the lipase.
濾液を減圧蒸留し、S −(+)−β−ヒドロキシブタ
ン酸エチル単離収ff14.7g、収率44.5%((
α) n= +17.3 @(C1,0,CHCl3)
)とR−(−)−β−ブチリルオキシブタン酸エチル単
離収1)6.3g、収ff132%((α)n=−o、
3°(cl、0゜CHCl3))をそれぞれ得た。The filtrate was distilled under reduced pressure to isolate ethyl S-(+)-β-hydroxybutanoate, yield ff14.7g, yield 44.5% ((
α) n= +17.3 @(C1,0,CHCl3)
) and R-(-)-β-butyryloxybutanoate ethyl isolated yield 1) 6.3 g, yield ff 132% ((α)n=-o,
3° (cl, 0° CHCl3)) were obtained, respectively.
実施例2
実施例1の方法に準じてラセミ体のβ−ヒドロキシブタ
ン酸ter t−ブチル37.6 g (0,235m
ol)を分割し、S−(+)−β−ヒドロキシブタン酸
ter を−ブチル(〔α) n= +28.2°(c
l、0.CHCh))単離収量7.8g (収率41%
)及びR−(−)−β−ブチリルオキシブタンfite
rt−ブチルα8=−0,07°(neat、 10セ
ル)単離収量16.2g (収率60%)をそれぞれ得
た。Example 2 37.6 g (0,235 m
ol) and S-(+)-β-hydroxybutanoic acid ter to -butyl([α) n= +28.2°(c
l, 0. CHCh)) Isolated yield 7.8 g (yield 41%
) and R-(-)-β-butyryloxybutane fite
An isolated yield of 16.2 g (60% yield) of rt-butyl α8=-0.07° (neat, 10 cells) was obtained in each case.
Claims (2)
る(R,S)−β−ヒドロキシ酸エステルに作用してR
−体、S−体のどちらか一方と優先的に適当なエステル
とエステル交換反応する能力を有する酵素の存在下に、 前記一般式で表される(R,S)−β−ヒドロキシ酸エ
ステルを実質的に水分の存在しない条件下で適当なエス
テルとエステル交換反応を行い、R−体、S−体のどち
らか一方に富む光学活性なβ−ヒドロキシ酸エステルと
、β−アシルオキシ酸エステルに分割することを特徴と
する光学活性エステルの製造法。(1) General formula: ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (X represents an alkyl group having 1 to 20 carbon atoms)
The (R,S)-β-hydroxy acid ester represented by the above general formula is converted into an (R,S)-β-hydroxy acid ester represented by the above general formula in the presence of an enzyme capable of transesterifying preferentially either the --form or the S-form with an appropriate ester. Perform a transesterification reaction with an appropriate ester under substantially water-free conditions to separate optically active β-hydroxy acid esters rich in either R-form or S-form and β-acyloxy acid esters. A method for producing an optically active ester, characterized by:
の範囲第1項記載の光学活性エステルの製造法。(2) The method for producing an optically active ester according to claim 1, wherein the appropriate ester is a triglyceride.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61256952A JPH0755158B2 (en) | 1986-10-30 | 1986-10-30 | Method for producing optically active ester |
US07/113,764 US4916074A (en) | 1986-10-30 | 1987-10-28 | Process for producing optically active compounds |
DE8787309625T DE3783327T2 (en) | 1986-10-30 | 1987-10-30 | METHOD FOR PRODUCING OPTICALLY ACTIVE CONNECTIONS. |
EP87309625A EP0266217B1 (en) | 1986-10-30 | 1987-10-30 | Process for producing optically active compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61256952A JPH0755158B2 (en) | 1986-10-30 | 1986-10-30 | Method for producing optically active ester |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63112998A true JPS63112998A (en) | 1988-05-18 |
JPH0755158B2 JPH0755158B2 (en) | 1995-06-14 |
Family
ID=17299642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61256952A Expired - Lifetime JPH0755158B2 (en) | 1986-10-30 | 1986-10-30 | Method for producing optically active ester |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0755158B2 (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02156899A (en) * | 1988-12-09 | 1990-06-15 | Chisso Corp | Optically active compound and production thereof |
JPH02219598A (en) * | 1989-02-21 | 1990-09-03 | Chisso Corp | Optically active compound and production thereof |
JP2015057427A (en) * | 2008-08-21 | 2015-03-26 | アイシス イノヴェイション リミテッド | Hydroxybutyric acid ester and medicinal uses of the same |
US9211275B2 (en) | 2008-01-04 | 2015-12-15 | Isis Innovation Ltd. | Ketone bodies and ketone body esters as blood lipid lowering agents |
US9579302B2 (en) | 2012-11-05 | 2017-02-28 | Tdeltas | Ketone bodies to protect tissues from damage by ionizing radiation |
US10051880B2 (en) | 2008-08-21 | 2018-08-21 | Oxford University Innovation Limited | Hydroxybutyrate ester and medical use thereof |
JP2019178122A (en) * | 2018-03-30 | 2019-10-17 | 大阪瓦斯株式会社 | Human normal cell activator |
JP2019178120A (en) * | 2018-03-30 | 2019-10-17 | 大阪瓦斯株式会社 | Human senescent cell activator |
US10660958B2 (en) | 2010-02-22 | 2020-05-26 | Tdeltas Limited | Nutritional composition |
US10821062B2 (en) | 2013-03-12 | 2020-11-03 | Tdeltas Limited | Compound for use in protecting skin |
US11230722B2 (en) | 2003-06-03 | 2022-01-25 | Oxford University Innovation Limited | Nutritional supplements and therapeutic compositions comprising (r)-3-hydroxybutyrate derivatives |
US11566268B2 (en) | 2013-03-14 | 2023-01-31 | Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services | Process for producing (R)-3-hydroxybutyl (R)-3-hydroxybutyrate |
-
1986
- 1986-10-30 JP JP61256952A patent/JPH0755158B2/en not_active Expired - Lifetime
Non-Patent Citations (1)
Title |
---|
J.AM.CHEM.SOC=1985 * |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02156899A (en) * | 1988-12-09 | 1990-06-15 | Chisso Corp | Optically active compound and production thereof |
JPH02219598A (en) * | 1989-02-21 | 1990-09-03 | Chisso Corp | Optically active compound and production thereof |
US11230722B2 (en) | 2003-06-03 | 2022-01-25 | Oxford University Innovation Limited | Nutritional supplements and therapeutic compositions comprising (r)-3-hydroxybutyrate derivatives |
US9211275B2 (en) | 2008-01-04 | 2015-12-15 | Isis Innovation Ltd. | Ketone bodies and ketone body esters as blood lipid lowering agents |
US10154982B2 (en) | 2008-01-04 | 2018-12-18 | Oxford University Innovation Limited | Ketone bodies and ketone body esters as blood lipid lowering agents |
US11311509B2 (en) | 2008-01-04 | 2022-04-26 | Oxford University Innovation Limited | Ketone bodies and ketone body esters as blood lipid lowering agents |
JP2015057427A (en) * | 2008-08-21 | 2015-03-26 | アイシス イノヴェイション リミテッド | Hydroxybutyric acid ester and medicinal uses of the same |
US10051880B2 (en) | 2008-08-21 | 2018-08-21 | Oxford University Innovation Limited | Hydroxybutyrate ester and medical use thereof |
US10660958B2 (en) | 2010-02-22 | 2020-05-26 | Tdeltas Limited | Nutritional composition |
US11571479B2 (en) | 2010-02-22 | 2023-02-07 | Tdeltas | Nutritional composition |
US9579302B2 (en) | 2012-11-05 | 2017-02-28 | Tdeltas | Ketone bodies to protect tissues from damage by ionizing radiation |
US10478415B2 (en) | 2012-11-05 | 2019-11-19 | Tdeltas Limited | Ketone bodies to protect tissues from damage by ionizing radiation |
US11234953B2 (en) | 2012-11-05 | 2022-02-01 | Tdeltas Limited | Ketone bodies to protect tissues from damage by ionizing radiation |
US10821062B2 (en) | 2013-03-12 | 2020-11-03 | Tdeltas Limited | Compound for use in protecting skin |
US11566268B2 (en) | 2013-03-14 | 2023-01-31 | Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services | Process for producing (R)-3-hydroxybutyl (R)-3-hydroxybutyrate |
JP2019178120A (en) * | 2018-03-30 | 2019-10-17 | 大阪瓦斯株式会社 | Human senescent cell activator |
JP2019178122A (en) * | 2018-03-30 | 2019-10-17 | 大阪瓦斯株式会社 | Human normal cell activator |
Also Published As
Publication number | Publication date |
---|---|
JPH0755158B2 (en) | 1995-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0266217B1 (en) | Process for producing optically active compounds | |
JP2707076B2 (en) | Production method of optically active compound | |
JP2691986B2 (en) | Process for producing optically active compound having pyridine skeleton | |
JPS63112998A (en) | Production of optically active ester | |
KR900004711A (en) | Method for preparing optically active-3-phenylglycolic acid ester | |
JPH03228694A (en) | Production of optically active hydroxylactones | |
JPH0436195A (en) | Production of optically active alpha-hydroxyesters | |
JPS63284184A (en) | Optically active compound and production thereof | |
JPS62166898A (en) | Production of optically active alcohol by biochemical technique | |
JP2726114B2 (en) | Process for producing optically active 3-chloro-1,2-propanediol and its esters | |
EP0528607B1 (en) | Process for preparing optically active 3-phenylglycidic acid esters | |
KR930002029B1 (en) | Optically active compound and process for producing them | |
JP2736075B2 (en) | Process for producing optically active 1,3-butanediol-1-benzyl ether and derivatives thereof | |
EP0783039B1 (en) | Process for producing optically active 2-alkoxycyclohexanol derivatives | |
EP0422768B1 (en) | Optically active monoester compounds and producing same | |
US5324852A (en) | 4-Substituted-2-hydroxybutanoates and a process for producing them | |
JP2690953B2 (en) | Process for producing optically active 1,3-butanediol and its derivatives | |
EP1428888B1 (en) | Method for the production of (1S,4R)-(-)-4-Hydroxycyclopent-2-enyl esters | |
JPH01132399A (en) | Production of optically active unsaturated alcohol and esterified product thereof | |
JPS6094091A (en) | Production of optically active carboxylic acid ester | |
JPS63123399A (en) | Production of optically active alcohol and ester | |
JPS63119693A (en) | Production of optically active alcohol and ester by biochemical technique | |
JPS6012992A (en) | Production of optically active carboxylic acid | |
JPS63169997A (en) | Production of optically active secondary alcohol and ester | |
JPH04166097A (en) | Production of optically active halohydrin derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |